MessengerJCHoKKYoungCHet al.The National Cardiovascular Data Registry (NCDR) data quality brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol. 2012;60:1484–8.
2.
CrimiGLeonardiSCostaFet al.Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. Insights from the all-comer PRODIGY trial. Catheter Cardiovasc Interv. 2015;86:E19–27.
3.
RihalCSTextorSCGrillDEet al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.
4.
PyxarasSASinagraGMangiacapraFet al.Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. Am J Cardiol. 2013;111:684–8.
5.
AkrawinthawongKRicciJCannonLet al.Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study. Ren Fail. 2015;37:187–91.
6.
TumlinJStaculFAdamAet al.Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006;98:14–20.
7.
PisaniARiccioEAndreucciMet al.Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy. Biomed Res Int. 2013;2013:868321.
8.
LumsdenCJSilvermanMZielinskiAet al.Vascular exchange in the kidney. Regional characterization by multiple indicator tomography. Circ Res. 1993;72:1172–80.
9.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Contrast-induced nephropathy: an “all or none” phenomenon?Angiology. 2015;66:508–13.
10.
NeumannFJSousa-UvaMAhlssonAet al.2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
11.
MehranRAymongEDNikolskyEet al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44(7):1393–9.
12.
BartholomewBAHarjaiKJDukkipatiSet al.Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93(12):1515–9.
13.
MarenziGLauriGAssanelliEet al.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44(9):1780–5.
14.
WykrzykowskaJJGargSOnumaYet al.Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘All-Comers’ LEADERS trial. Circ Cardiovasc Interv. 2011;4(1):47–56.
15.
OzturkDCelikOErturkMet al.Utility of the logistic clinical Syntax Score in the prediction of contrast-induced nephropathy after primary percutaneous coronary intervention. Can J Cardiol. 2016;32(2):240–6.
16.
AksuUGulcuOAksakalEKalkanKTopcuS. Long-term mortality and contrast-induced nephropathy. Angiology. 2019:3319718823628.
